Comment on “Anatomical and functional changes after dexamethasone implant and ranibizumab in diabetic macular edema:a retrospective cohort study”

• 作者: Dan Calugaru Mihai Calugaru
• 来源期刊: 国际眼科杂志:英文版
• 学科: 医学
• 关键词: Irvine RANIBIZUMAB treatment
• 年，卷（期）: 2020,（10）
• 页码范围: 1678-1680
• 页数: 3页
• 分类号: R587.2

摘要

Dear Editor,The study by Mastropasqua et al[1]evaluated the efficacy and safety of ranibizumab(Lucentis;Genentech,Inc.,South San Francisco,CA,USA;RBZ group)and dexamethasone implant(Ozurdex;Allergan Irvine.,CA,USA;DEX group)intravitreal treatments in 50 patients with treatment-naive center involved diabetic macular edema(DME)by means of functional and morphological assessments during a 6-month follow-up.